Image
  • About Us
  • Team
  • Portfolio
  • Philanthropy
  • Trending
  • Contact
  • Login

Argos Therapeutics Announces New Data Demonstrating Prolonged Overall Survival in a Phase 2 Study of its Arcelis™ Immunotherapy AGS-003

admin February 4, 2012 Portfolio News

SOURCE: Argo Therapeutics

Back

Topics

News Archives

Image
Privacy Policy Terms of Use©2022 Lumira Ventures
  • About Us
  • Team
  • Portfolio
  • Philanthropy
  • Trending
  • Contact
  • Login